• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑血管合并症对日本经皮冠状动脉介入治疗患者预后的影响:来自日本多中心注册研究(KICS)的 1 年数据。

Impact of cerebrovascular comorbidity on prognosis in Japanese patients undergoing PCI: 1-year data from Japanese multicenter registry (KICS).

机构信息

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.

出版信息

Heart Vessels. 2022 Jun;37(6):911-918. doi: 10.1007/s00380-021-01997-7. Epub 2022 Jan 11.

DOI:10.1007/s00380-021-01997-7
PMID:35013771
Abstract

Cardiovascular and cerebrovascular diseases are considered the principal cause of morbidity and mortality worldwide; the effect of stroke-induced cardiac manifestations is well recognized; however, not enough clinical data have been found about the impact of stroke with underlying cardiac disease. This study's objective is to assess the impact of stroke on the prognosis of patients with underlying IHD, who underwent PCI treatment. This was a multicenter, 1-year observational study in patients undergoing PCI in one of the 17 participating centers across Japan. 18,495 patients were registered on the PCI list; 2481 patients had a prior stroke experience, whereas 15,979 were stroke-free. Our study revealed that stroke patients were significantly older (mean age 73.5 ± 9.6, 69.7(± 11.5), respectively), and suffered from more comorbidities (diabetes, hypertension, and chronic kidney disease, p < 0.0001). During the 1-year period, subjects with stroke showed higher incidence of clinical events compared to those without stroke; to illustrate, all-cause death accounted for 6.2% in patients with stroke, in contrast to only 2.8% in stroke-free patients (p < 0.0001), cardiac death amounted for 2.2 and 1.2%, respectively (p < 0.0001), recurrent stroke for 3.1% and 1.2% (p < 0.0001), non-cardiac death for 3.6 and 1.54% (p < 0.0001), and finally, hemorrhagic complications with 2.6 and 1.3% (p < 0.0001). Kaplan-Meier analysis revealed that stroke patients had a higher probability of all-cause mortality, cardiac death, and recurrent stroke (log-rank p < 0.0001). Cox hazard analysis also showed that the presence of stroke is a significant indicator in determining the outcome of cardiac death (HR = 1.457, 95% CI 1.036-2.051, p = 0.031); hence, proving it to be a crucial predictor on cardiac prognosis. History of prior stroke was common in PCI patients, and independently associated with a higher rate of subsequent cardiovascular and cerebrovascular events recurrence. Thus, highlighting an urgent need for comprehensive prevention of cardiac and cerebrovascular diseases.

摘要

心脑血管疾病被认为是全球发病率和死亡率的主要原因;中风引起的心脏表现的影响已得到充分认识;然而,关于潜在心脏病患者中风的影响,尚未发现足够的临床数据。本研究旨在评估中风对接受 PCI 治疗的潜在 IHD 患者预后的影响。这是一项在日本 17 个参与中心之一进行的多中心、为期 1 年的 PCI 患者观察研究。18495 名患者在 PCI 名单上登记;2481 名患者有中风史,而 15979 名患者无中风史。我们的研究表明,中风患者年龄明显较大(平均年龄 73.5 ± 9.6,69.7(±11.5),分别),并患有更多的合并症(糖尿病、高血压和慢性肾病,p<0.0001)。在 1 年期间,与无中风患者相比,中风患者发生临床事件的发生率更高;具体来说,中风患者的全因死亡率为 6.2%,而无中风患者的死亡率仅为 2.8%(p<0.0001),心源性死亡率分别为 2.2%和 1.2%(p<0.0001),复发性中风为 3.1%和 1.2%(p<0.0001),非心源性死亡为 3.6%和 1.54%(p<0.0001),最后,出血并发症为 2.6%和 1.3%(p<0.0001)。Kaplan-Meier 分析显示,中风患者全因死亡率、心源性死亡率和复发性中风的概率更高(对数秩 p<0.0001)。Cox 风险分析还表明,中风的存在是确定心源性死亡结果的一个重要指标(HR=1.457,95%CI 1.036-2.051,p=0.031);因此,证明它是心脏预后的一个关键预测因素。既往中风史在 PCI 患者中很常见,且与随后心血管和脑血管事件复发的发生率增加独立相关。因此,突出了对心脏和脑血管疾病进行全面预防的迫切需要。

相似文献

1
Impact of cerebrovascular comorbidity on prognosis in Japanese patients undergoing PCI: 1-year data from Japanese multicenter registry (KICS).脑血管合并症对日本经皮冠状动脉介入治疗患者预后的影响:来自日本多中心注册研究(KICS)的 1 年数据。
Heart Vessels. 2022 Jun;37(6):911-918. doi: 10.1007/s00380-021-01997-7. Epub 2022 Jan 11.
2
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].[经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉分叉病变的长期预后比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.
3
Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - .非保护左主干冠状动脉疾病中经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较——CREDO-Kyoto PCI/CABG注册队列2的5年结果
Circ J. 2015;79(6):1282-9. doi: 10.1253/circj.CJ-15-0034. Epub 2015 Mar 30.
4
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).三维分叉角度对左主干冠状动脉疾病经皮冠状动脉介入治疗后 5 年预后的影响:SYNTAX 试验(紫杉醇药物洗脱支架与心脏搭桥术的联合治疗)的一项亚组研究。
JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009.
5
Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.经皮冠状动脉介入治疗后后续急性冠状动脉综合征和计划性血运重建对长期死亡率的预后影响:来自日本多中心注册研究的报告。
J Am Heart Assoc. 2017 Oct 27;6(11):e006529. doi: 10.1161/JAHA.117.006529.
6
Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry.药物洗脱支架经皮冠状动脉介入治疗在无保护左主干与非左主干原生冠状动脉疾病中的疗效:来自前瞻性多中心德国 DES.DE 注册研究的结果。
Clin Res Cardiol. 2013 Sep;102(9):679-86. doi: 10.1007/s00392-013-0582-1. Epub 2013 May 17.
7
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.DELTA 注册研究:非保护左主干冠状动脉开口/中段病变行经皮冠状动脉介入治疗与冠状动脉旁路移植术的长期临床结果:多中心注册研究评估左主干病变的经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗
JACC Cardiovasc Interv. 2014 Apr;7(4):354-61. doi: 10.1016/j.jcin.2013.11.014. Epub 2014 Mar 14.
8
[Clinical characteristics and prognosis in the patients of stroke after percutaneous coronary intervention].经皮冠状动脉介入治疗后卒中患者的临床特征与预后
Zhonghua Yi Xue Za Zhi. 2017 Oct 24;97(39):3051-3056. doi: 10.3760/cma.j.issn.0376-2491.2017.39.003.
9
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.经皮冠状动脉介入治疗后急性冠状动脉综合征患者中风对死亡率的发生率、预测因素及影响——来自 PROMETHEUS 登记研究的结果。
Catheter Cardiovasc Interv. 2020 Apr 1;95(5):885-892. doi: 10.1002/ccd.28369. Epub 2019 Jun 14.
10
[Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].冠状动脉疾病且左心室射血分数低于50%的患者接受经皮冠状动脉介入治疗的结果
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1058-1066. doi: 10.3760/cma.j.issn.0253-3758.2017.12.010.

引用本文的文献

1
Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.140 万例经皮冠状动脉介入治疗患者的心脏外血管疾病对结局的影响。
Catheter Cardiovasc Interv. 2022 Nov;100(5):737-746. doi: 10.1002/ccd.30404. Epub 2022 Sep 21.
2
Clinical utility of the BIWACO score for patients with atrial fibrillation after percutaneous coronary intervention.经皮冠状动脉介入治疗后心房颤动患者 BIWACO 评分的临床实用性。
Heart Vessels. 2023 Jan;38(1):96-105. doi: 10.1007/s00380-022-02128-6. Epub 2022 Jul 23.